Report Code: CMI50427

Published Date: June 2024

Pages: 320+

Category: India

Reports Description

India Tissue Engineering Market was valued at USD 352.6 Million in 2024 and is expected to reach USD 598.2 Million by 2033, at a CAGR of 11.1% during the forecast period 2024 – 2033.

Tissue engineering is an interdisciplinary field combining principles of engineering, biology, and medicine to create functional biological substitutes for damaged or diseased tissues. This involves the design and fabrication of scaffolds, often using biomaterials, which mimic the extracellular matrix of native tissues.

India Tissue Engineering Market: Growth Factors

Advancements in technology

Advancements in technology are propelling India’s tissue engineering market forward by facilitating innovative approaches to regenerative medicine and organ transplantation. Cutting-edge technologies such as 3D bioprinting enable the precise layering of cells, scaffolds, and growth factors to create complex tissue structures, mimicking the natural architecture of organs.

This allows for the customization of tissue constructs tailored to individual patient needs, promoting enhanced compatibility and reducing the risk of rejection. Furthermore, the development of novel biomaterials with tenable properties, such as biodegradability and mechanical strength, expands the possibilities for tissue engineering applications.

Advancements in imaging techniques, such as MRI and CT scans, provide detailed insights into tissue structure and function, aiding in the design and evaluation of engineered tissues. Additionally, progress in stem cell research and gene editing technologies offer promising avenues for generating functional cells for tissue regeneration.

These technological advancements not only drive research and development efforts in academia and industry but also pave the way for clinical translation, fostering the growth of the tissue engineering market in India and addressing healthcare challenges related to organ shortage and chronic diseases.

Demand for regenerative medicine

The burgeoning demand for regenerative medicine is steering India’s tissue engineering market toward substantial growth. Regenerative medicine, a field focused on repairing or replacing damaged tissues and organs, holds immense promise for addressing a myriad of medical conditions and improving patient outcomes.

In India, where there is a pressing need for advanced healthcare solutions due to a large population and a high burden of chronic diseases, regenerative medicine offers hope for more effective treatments. Tissue engineering, a key component of regenerative medicine, involves the development of biological substitutes to restore, maintain, or improve tissue function.

This technology holds significant potential for addressing challenges such as organ shortages, chronic wounds, and degenerative diseases.

As the demand for innovative medical interventions grows, driven by factors like an aging population, increasing healthcare expenditure, and a rise in chronic ailments, the Indian tissue engineering market stands to benefit substantially.

Moreover, the Indian government’s initiatives to promote research and development in biotechnology and healthcare further bolster the growth prospects for tissue engineering technologies. By harnessing the power of regenerative medicine and tissue engineering, India is poised to revolutionize its healthcare landscape, offering new hope and solutions to patients across the country.

India Tissue Engineering Market: Restraints

High development costs

High development costs significantly hinder the growth of the tissue engineering market in India. Tissue engineering involves a complex process of research, development, and production of biomaterials and scaffolds that mimic the structure and function of human tissues.

These materials often require specialized equipment and expertise, which can be expensive to acquire and maintain. Moreover, conducting clinical trials to ensure the safety and efficacy of tissue-engineered products further adds to the costs.

In India, where healthcare resources are already stretched thin, investing in tissue engineering research and development competes with other pressing healthcare needs. Additionally, stringent regulatory requirements increase the time and resources needed to bring tissue-engineered products to market.

The lack of robust infrastructure and funding opportunities for tissue engineering research exacerbates these challenges, making it difficult for Indian companies and research institutions to compete on a global scale.

Consequently, high development costs create barriers to entry for smaller players and limit the overall growth potential of the tissue engineering market in India, hindering the country’s ability to harness the full potential of this transformative technology.

India Tissue Engineering Market: Opportunities

Increasing healthcare expenditure

The increasing healthcare expenditure in India has been a significant driving force behind the growth of the tissue engineering market in the country. As healthcare spending rises, there is a heightened demand for advanced medical technologies and treatments that can address complex health issues more effectively.

Tissue engineering, which involves the development of biological substitutes to restore, maintain, or improve tissue function, has emerged as a promising solution for a wide range of medical conditions, including organ failure, tissue damage, and chronic diseases.

With greater investment in healthcare infrastructure, research, and development, India is witnessing a surge in tissue engineering initiatives aimed at innovating regenerative therapies, organ transplantation, and tissue repair techniques.

This increased focus on tissue engineering is not only driven by the need for more efficient medical interventions but also by the potential to reduce healthcare costs in the long run by offering alternatives to traditional treatments such as organ transplants and long-term medication.

Moreover, as the Indian population continues to grow and age, there is a pressing need for solutions to address age-related diseases and injuries, further catalysing the demand for tissue engineering technologies and driving market expansion. Overall, the rise in healthcare expenditure is fuelling innovation and investment in tissue engineering, positioning India as a key player in this rapidly evolving field.

India Tissue Engineering Market: Segmentation Analysis

India Tissue Engineering market is segmented by product, application and region.  Based on product, the market is classified into Synthetic Scaffold Material, Biologically Derived Scaffold Material and Others. Synthetic Scaffold Materials dominated the market in 2023 with a market share of 55.1% and are expected to keep their dominance during the forecast period 2024-2033.

Synthetic scaffold materials play a pivotal role in propelling the tissue engineering market in India. These scaffolds serve as a framework for the growth and regeneration of tissues and organs by providing mechanical support and a conducive environment for cell attachment, proliferation, and differentiation.

India, with its burgeoning population and increasing healthcare demands, is witnessing a surge in tissue engineering research and applications.

Synthetic scaffolds offer several advantages, including tenable properties such as porosity, pore size, and mechanical strength, which can be tailored to mimic the native tissue microenvironment. This customization enables researchers and clinicians to address specific tissue engineering challenges and requirements, ranging from bone regeneration to cartilage repair and organ transplantation.

Moreover, synthetic scaffolds can be manufactured reproducibly and cost-effectively, making them suitable for large-scale production and commercialization.

As India strives to enhance its healthcare infrastructure and address the growing burden of chronic diseases and injuries, the integration of synthetic scaffold materials into tissue engineering strategies holds immense promise for developing advanced therapies and medical solutions tailored to the needs of the Indian population.

Thus, the adoption of synthetic scaffold materials is driving innovation and growth within India’s tissue engineering sector, positioning the country as a key player in the global regenerative medicine landscape.

Based on application, the market is classified into orthopaedics and musculoskeletal, neurology, cardiovascular, skin and integumentary, dental, and others. Orthopaedics and Musculoskeletal dominated the market in 2023 with a market share of 33.9% and is expected to keep its dominance during the forecast period 2024-2033.

In India, the field of orthopaedics and musculoskeletal disorders plays a pivotal role in driving the tissue engineering market due to the pressing need for innovative solutions to address the country’s significant healthcare challenges.

With an aging population and an increasing incidence of orthopedic injuries and musculoskeletal disorders, such as osteoarthritis and osteoporosis, there is a growing demand for effective treatments that can promote tissue regeneration and repair.

Tissue engineering offers promising solutions by leveraging advancements in biomaterials, cell biology, and bioengineering to develop engineered tissues and biomimetic scaffolds tailored to the specific needs of patients. In orthopedics, tissue-engineered constructs hold immense potential for repairing damaged cartilage, bones, and ligaments, offering alternatives to traditional treatments like joint replacement surgery.

Furthermore, the prevalence of sports-related injuries and road accidents in India underscores the urgency for regenerative therapies that can restore function and mobility.

The collaboration between orthopedic surgeons, researchers, and biotech companies is driving innovation in tissue engineering, leading to the development of novel products and therapies that aim to revolutionize the management of orthopedic conditions in India and beyond.

As the healthcare landscape evolves and the demand for personalized medicine grows, the integration of tissue engineering technologies into clinical practice is poised to make a substantial impact, offering hope for improved outcomes and quality of life for patients with orthopedic and musculoskeletal disorders in India.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 352.6 Million
Projected Market Size in 2033 USD 598.2 Million
Market Size in 2023 USD 351.3 Million
CAGR Growth Rate 11.1% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product, Application and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Country Scope India
Buying Options Request tailored purchasing options to fulfil your requirements for research.

India Tissue Engineering Market: Regional Analysis

India Tissue Engineering market is segmented into East India, West India, North India and South India. West India dominated the India Tissue Engineering market in 2023 with a market share of 39.4% and is expected to keep its dominance during the forecast period 2024-2033.

The West Indian region plays a pivotal role in propelling India’s tissue engineering market forward due to several key factors. Firstly, the region hosts a burgeoning biotechnology and pharmaceutical industry, fostering innovation and research collaborations in tissue engineering.

Major cities like Mumbai and Pune are home to leading research institutions and biotech companies, attracting talent and investment to drive advancements in regenerative medicine.

Additionally, the presence of world-class healthcare facilities and a growing emphasis on medical tourism in cities like Goa and Gujarat create a demand for cutting-edge tissue engineering solutions.

Furthermore, the West Indian states boast strong government support and initiatives to promote research and development in biotechnology, including tissue engineering. Schemes such as financial incentives, grants, and partnerships between academia, industry, and government entities foster a conducive ecosystem for the growth of tissue engineering initiatives.

Leveraging these factors, the West Indian region emerges as a dynamic hub for tissue engineering innovation, contributing significantly to India’s overall progress in this field.

India Tissue Engineering Market: Recent Developments

  • In January 2023, BioMed X and AbbVie extended their research partnership, as reported by the independent biomedical research organization.
  • In June 2022, Scientists at the Indian Institute of Science developed a new bioink that can be used in 3D bioprinting to create functional human organs. The bioink is made from a combination of living cells and a hydrogel that mimics the extracellular matrix, providing a supportive environment for cell growth.
  • In August 2019, Indian Institute of Technology Hyderabad Researchers derived collagen from waste eel skin and showed that tissue scaffolds built using such collagen allow the growth and proliferation of stem cells. The practical applications of this research can lead to utilising eel fish skin-derived collagen as a promising alternative to animal derived collagen, which is expensive and associated with pathological diseases.

List of the prominent players in the India Tissue Engineering Market:

  • Stempeutics Research
  • TissueTech India
  • Stryker Corporation
  • Advanced Enzyme Technologies
  • Vyome Therapeutics
  • 3M India
  • Nutech Mediworld
  • LifeCell International
  • Tissue Regenix Group
  • TTK Healthcare
  • Others

These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The India Tissue Engineering Market is segmented as follows:

By Product

  • Synthetic Scaffold Material
  • Biologically Derived Scaffold Material
  • Others

By Application

  • Orthopedics and Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin and Integumentary
  • Dental
  • Others

By Product Type

  • Scaffold, By Material
    • Synthetic Material
    • Biological Material
      • Collagen
      • Hydrogel
      • Stem Cells
      • Others
  • Tissue Grafts, By Type
    • Allograft
    • Autograft
    • Synthetic Grafts
    • Xenograft
  • Other Products

By End User

  • Hospitals
  • Specialty Centers and Clinics
  • Ambulatory Surgical Centers

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 India Tissue Engineering Market, (2024 – 2033) (USD Million)
    • 2.2 India Tissue Engineering Market: snapshot
  • Chapter 3. India Tissue Engineering Market – Industry Analysis
    • 3.1 India Tissue Engineering Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Advancements in Technology
      • 3.2.2 Demand for regenerative medicine
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Product
      • 3.7.2 Market Attractiveness Analysis By Application
  • Chapter 4. India Tissue Engineering Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 India Tissue Engineering Market: Company Market Share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. India Tissue Engineering Market – Product Analysis
    • 5.1 India Tissue Engineering Market Overview: By Product
      • 5.1.1 India Tissue Engineering Market Share, By Product, 2023 and 2033
    • 5.2 Synthetic Scaffold Material
      • 5.2.1 India Tissue Engineering Market by Synthetic Scaffold Material, 2024 – 2033 (USD Million)
    • 5.3 Biologically Derived Scaffold Material
      • 5.3.1 India Tissue Engineering Market by Biologically Derived Scaffold Material, 2024 – 2033 (USD Million)
    • 5.4 Others
      • 5.4.1 India Tissue Engineering Market by Others, 2024 – 2033 (USD Million)
  • Chapter 6. India Tissue Engineering Market – Application Analysis
    • 6.1 India Tissue Engineering Market Overview: By Application
      • 6.1.1 India Tissue Engineering Market Share, By Application, 2023 and 2033
    • 6.2 Orthopedics and Musculoskeletal
      • 6.2.1 India Tissue Engineering Market by Orthopedics and Musculoskeletal, 2024 – 2033 (USD Million)
    • 6.3 Neurology
      • 6.3.1 India Tissue Engineering Market by Neurology, 2024 – 2033 (USD Million)
    • 6.4 Cardiovascular
      • 6.4.1 India Tissue Engineering Market by Cardiovascular, 2024 – 2033 (USD Million)
    • 6.5 Skin and Integumentary
      • 6.5.1 India Tissue Engineering Market by Skin and Integumentary, 2024 – 2033 (USD Million)
    • 6.6 Dental
      • 6.6.1 India Tissue Engineering Market by Dental, 2024 – 2033 (USD Million)
    • 6.7 Others
      • 6.7.1 India Tissue Engineering Market by Others, 2024 – 2033 (USD Million)
  • Chapter 7. India Tissue Engineering Market – Regional Analysis
    • 7.1 India Tissue Engineering Market Regional Overview
    • 7.2 India Tissue Engineering Market Share, by Region, 2023 & 2033 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 Stempeutics Research
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 TissueTech India
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Stryker Corporation
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Advanced Enzyme Technologies
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Vyome Therapeutics
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 3M India
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Nutech Mediworld
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 LifeCell International
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Tissue Regenix Group
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 TTK Healthcare
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Others.
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
List Of Figures

Figures No 1 to 18

List Of Tables

Tables No 1 to 2

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2033

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2033
  • Market revenue estimates and forecasts up to 2033, by technology
  • Market revenue estimates and forecasts up to 2033, by application
  • Market revenue estimates and forecasts up to 2033, by type
  • Market revenue estimates and forecasts up to 2033, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Stempeutics Research
  • TissueTech India
  • Stryker Corporation
  • Advanced Enzyme Technologies
  • Vyome Therapeutics
  • 3M India
  • Nutech Mediworld
  • LifeCell International
  • Tissue Regenix Group
  • TTK Healthcare
  • Others

FAQs

The restraints of the India Tissue Engineering  market is high development costs.

The major driver for the India Tissue Engineering market is advancements in technology and demand for regenerative medicine.

The “Orthopedics and Musculoskeletal” had the largest share in the market for India Tissue Engineering.

The “Synthetic Scaffold Material” category dominated the market in 2023.

The key players in the market are Stempeutics Research, TissueTech India, Stryker Corporation, Advanced Enzyme Technologies, Vyome Therapeutics, 3M India, Nutech Mediworld, LifeCell International, Tissue Regenix Group, TTK Healthcare, Others.

The market is projected to grow at a CAGR of 11.1% during the forecast period, 2024-2033.

The India Tissue Engineering Market size was valued at USD 352.6 Million in 2024.

PURCHASE OPTIONS

$

2890


$

3890


$

4890


$

1890


$

2290

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?
100% FREE CUSTOMIZATION!